ReviewLeukemia & lymphoma2014

Emerging therapeutic paradigms to target the dysregulated Janus kinase/signal transducer and activator of transcription pathway in hematological malignancies.

Tariq I Mughal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.